Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.5.2145

PBK/TOPK Expression During TPA-Induced HL-60 Leukemic Cell Differentiation  

Liu, Yu-Hong (Department of Hematology, The Affiliated Hospital of Yan'an University)
Gao, Xue-Mei (Department of Hematology, The Affiliated Hospital of Yan'an University)
Ge, Fan-Mei (Department of Hematology, The Affiliated Hospital of Yan'an University)
Wang, Zhe (Department of Pathology, School of Basic Medicine, Fourth Military Medical University)
Wang, Wen-Qing (Department of Pathology, School of Basic Medicine, Fourth Military Medical University)
Li, Xiao-Yong (Department of General Surgery, The Affiliated Hospital of Yan'an University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.5, 2012 , pp. 2145-2148 More about this Journal
Abstract
Objective: This study concerns expression of PBK/TOPK during differentiation of HL-60 leukemic cells induced by tetradecanoyl phorbol acetate (TPA). Methods: Wright-Giemsa staining was performed to observe morphological changes in the HL-60 cells, and flow cytometry was used to assess the cell cycle and CD11b, CD14, CD13, and CD33 expression. PBK/TOPK levels were determined by Western blot analysis. Results: After treating HL60 cells with $5.1{\times}10^{-9}$ mmol/L of TPA for three days, the number of nitroblue-tetrazolium-positive cells and CD11b, CD13, and CD14 expression increased, whereas the PBK/TOPK levels decreased. Conclusions: TPA can inhibit proliferation and induce differentiation of HL60 cells of the granulocytic or monocytic lineage. PBK/TOPK expression was downregulated during this process, whereas the Pho-PBK/TOPK expression was increased.
Keywords
HL-60 cells; PBK/TOPK; differentiation; TPA;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Dong C, Davis RJ, Flavell RA (2001). Signaling by the JNK group of MAP kinases. c-jun N-terminal Kinase. J Clin Immunol, 21, 253-7.   DOI
2 Drew BA, Burow ME, Beckman BS (2012). MEK5/ERK5 pathway: the first fifteen years. Biochim Biophys Acta, 1825, 37-48.
3 Gaudet S, Branton D, Lue RA (2000). Characterization of PDZbinding kinase, a mitotic kinase. Proc Natl Acad Sci U S A, 97, 5167-72.   DOI
4 He F, Yan Q, Fan L, et al (2010). PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma. Hum Pathol, 41, 415-24.   DOI
5 Huang S, Shen Q, Mao WG, et al (2006). JWA, a novel signaling molecule, involved in all-trans retinoic acid induced differentiation of HL-60 cells. J Biomed Sci, 13, 357-71.   DOI
6 Kobel M, Pohl G, Schmitt WD, et al (2005). Activation of mitogen-activated protein kinase is required for migration and invasion of placental site trophoblastic tumor. Am J Pathol, 167, 879-85.   DOI
7 Liu J, Lei DP, Jin T, et al (2011). Altered expression of miR- 21 and PTEN in human laryngeal and hypopharyngeal squamous cell carcinomas. Asian Pac J Cancer Prev, 12, 2653-7.
8 Liu P, Wang X, Hu C, Hu T (2011). Inhibition of proliferation and induction of apoptosis by trimethoxyl stilbene (TMS) in a lung cancer cell line. Asian Pac J Cancer Prev, 12, 2263-9.
9 Macfarlane DE, Manzel L (1994). Activation of $\beta$-isozyme of protein kinase C($PKC{\beta}$) is necessary and sufficient for phorbol ester induced differdentiation of HL-60 promyelocytes. J Biol Chem, 269, 4327-31.
10 Meinhardt G, Eppinger E, Schmidmaier R (2002). Effect of novel modulators of protein kinase C activity upon kinase activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemia cells. Anticancer Drugs, 13, 725-31.   DOI
11 Nandi A, Tidwell M, Karp J, et al (2004). Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells. Blood Cells Mol Dis, 32, 240-5.   DOI
12 Nandi AK, Rapoport AP (2006). Expression of PDZbinding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF. Leuk Res, 30, 437-47.   DOI
13 Nakaya K, Nabata Y, Ichiyanagi T, et al (2012). Stimulation of dendritic cell maturation and induction of apoptosis in leukemia cells by a heat-stable extract from azuki bean (vigna angularis), a promising immunopotentiating food and dietary supplement for cancer prevention. Asian Pac J Cancer Prev, 13, 607-11.   DOI   ScienceOn
14 Obata T, Brown GE, Yaffe MB (2000). MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit Care Med, 28, N67-77.   DOI
15 Park JH, Lin ML, Nishidate T, et al (2006). PDZ-binding kinase/T-LAK cell originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer. Cancer Res, 66, 9186-95.   DOI
16 Raviv Z, Kalie E, Seger R (2004). MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation. J Cell Sci, 117, 1773-84.   DOI
17 Reddy KB, Nabha SM, Atanaskova N (2003). Role of MAPkinase in tumor progression and invasion. Cancer Metastasis Rev, 22, 395-403.   DOI   ScienceOn
18 Yuryev A, Wennogle LP (2003). Novel Raf kinase proteinprotein interactions found by an exhaustive yeast two-hybrid analysis. Genomics, 81, 112-5.   DOI
19 Simons-Evelyn MK, Bailey D, Toretsky JA, et al (2001). PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells. Blood Cells Mol Dis, 27, 825-9.   DOI
20 Yamamoto S, Tamai H, Ishisaka R, et al (2000). Mechanism of alpha-tocopheryl succinate-induced apoptosis of promyelocytic leukemia cell. Free Radic Res, 33, 407-18.   DOI
21 Cote S, Simard C, Lemieux R (2002). Regulation of growthrelated genes by interleukin-6 in murine myeloma cells. Cytokine, 20, 113-20.   DOI
22 Abe Y, Matsumoto S, Kito K, et al (2000). Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. J Biol Chem, 275, 21525-31.   DOI
23 Ayllon V, O'connor R (2007). PBK/TOPK promotes tummor cell proliferation through P38 MAPK activity and regulation of the DNA damage response. Oncogene, 26, 3451-61.   DOI
24 Beltran JA, Peek J, Chang SL (2006). Expression and regulation of the mu opioid peptide receptor in TPA-differentiated HL-60 promyelocytic leukemia cells. Int Immunopharmacol, 6, 1331-40.   DOI